VEGF: Médiateur de l'angiogenèse hypoxique

Medecine/Sciences

Volumn 13, Issue 6-7, 1997, Pages 886-891

  Freiin, Christian ^a,b   Ladoux, Annie ^a   Banters, Christophe ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744461654     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/480     Document Type: Article

References (43)

1. PlouetJ, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBOJ1989; 8: 3801-6.
2. LeungDW, Cachianes G, Kuang WJ, Gddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
3. Connolly DT, Olander JV, Heuvehnan D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder I. Human vascular permeability factor. Isolation from U937 cells./AW them 1989; 264: 20017-24.
4. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhck A, Harpal K, Eberhard! C, Declercq C, Pawling 1, Moons L, Collen D, Risan W, Nag)' A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-9.
5. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KI, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-42.
6. Waltenberger 1, Claesson-Welsh L, Siegbalm A, Shibuya M, Heldin CH. DifTerenual signal transduction properties of KDR and Flt-1, nvo receptors for vascular endothelial growth factor.JBiol Client 1994; 269: 269S8-9o.
7. Shalaby F, RossantJ, Yamaguchi TP, Gertsenstein M, Wu XK, Breitman ML, Schuh AC. Failure of blood island formation and vasculogenesis in Flk-1 deficient mice. Nature 1993; 376: 62-6.
8. Fonc GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66-70.
9. Sato TN, Tozawa Y, Deutsch U, WolburgBuchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1993; 376: 70-4.
10. Maglione D, Guerrerio V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to vascular endothelialgrowth factor. Pi-oc Natl Acad Sri. USA 1991 ; 88: 9267-71.
11. Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vechio S, Lei K), Chou JY, Persico MG. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (P1GT) are transcribed from a single gene of chromosome 14. Oncogens 1993; 8: 925-31.
12. Park JE, Chen HH, Winer I, Houck KA, Ferrara N. Placental growth factor. / Biol Chem 1994; 269: 2564&-S4.
13. DiSalvoJ, Ba>-ne ML, Conn G, Kwok PW, Trivedi PG, Soderman PD, Palisi TM, Sulli\-an KA, Thomas KA. Purification and characterization of a naturally occurring vascular endothelial growth factor-placental ?rowth factor heterodimer. / Biol Chem 995 ; 270: 7717-23.
14. Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang MLS. Heterodimers of placenta! growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression and high affinity binding to flk-1/KDR. I Biol CKem 1996; 271: 3f54-62.
15. Olofsson B, Pajusola K, Kaipainen A, Von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Ericksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. ProcNatlAcad Sei USA 1996; 93: 2576-81.
16. Iptikov V, Pajusola K, Kaipanen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR2) receptor tyrosine kinase. EMBO 11996; 15: 290%.
17. Kaipanen A, Korhonen J, Mustonen T, Van Hinsbergh VWM, Fang GH, Dumont D, Breitman M, Alitalo K. Expression of the fins-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Pnc Natl Acad Sei USA 1995; 92:3566-70.
18. Lyttle DJ, Fraser KM, Fleming SB, Mercer AA, Robinson AI. Homologs of vascular endothelial growth factor are encoded by the poxvirus orfvirus./ Virol 1994; 68: 84-92.
19. Ladoux A, Frelin C. Hvpoxia is a strong inducer of vascular endotnelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993; 195: 1005-10.
20. Tischer E, Mitchell R, Hartman T, Sih-a M, Gospodarowicz D, FiddesJC, Abraham J. The human gene for vascular endothelial growth factor. J Biol Cltem 1991 ; 266: 11947-55.
21. Goldberg MA, Schneider TJ. Similarities between the oxygen sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. / Biol Chem 1994; 269: 4355-9.
22. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. Hypoxia inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. ProcNatl Acad Set USA 1991 ; 86: 2301-5.
23. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia induced factor-1 is a basic helix loop helix PAS heterodimer regulated by O2 tension. ProcNatlAcad Sri USA 1995; 92:5510-4.
24. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of vascular endothelial growth factor by hypoxia. / Biol Chem 1995; 270: 13333-40.
25. Ladoux A, Frelin C. Cobalt stimulates the expression of vascular endothelial growth factor mRNA in rat cardiac cells. Biochem Biophys Res Commun 1994; 204: 794-8.
26. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxie induction of human vascular endotnelial growth factor expresion through c-Src activation. Nature 1995; 375: 577-81.
27. Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial frowth factor gene expression. Cancer Res 995; 55: 6161-5.
28. Levj AP, Levy NS, Goldberg i\IA. Posttranscriptional regulation of oscular endothelial growth factor by hypoxia. / Biol Chem 1996:271:2746-53.
29. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxiainduced vascular endothelial growth factor (VEGF) expression by neuroglia. / Neurosd 1995; 15:4738-47.
30. Schweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis. Nature 1992; 359: 843-5.
31. Graber TG, Osmanian C, Tacks T, Housman DE, Koch CI, Löwe SW, Giaccia AT. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 3/9: 88-91.
32. Kloner S, Shook RA, Przyklenk K, Darä VG, Junio L, Matdiews RV, Bumstein S, Gibson M, Poole K, Cannon CP, McCabe CH, Braum\-ald E. Previous angina alters in-hospital outcome in TIMI-4. Circulation 1995 ; 91:37-47.
33. Speechly-Dick ME, Groover GS, Yellon DM. Does ischémie preconditionningin die human involves protein kinase C and ATP dependent K channels. Ore Res 1995; 77:1030-5
34. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y. Rapid expression of vascular endothelial growth factor by transient ischemia in rat heart. Am JPhysiol 1994; 267 : H1948-4.
35. Kirn KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature 1991; 362: 841-4.
36. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Nail Acad Sei USA 1995 ; 92: 10457-61.
37. Millauer B, Shawer LK, Plate KH, Risau W, Ullrich A- Gliobastoma growth inhibited in vivoby a dominant negative Flk-1 mutant. Afc/ure 1994; 367:57&-9.
38. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischémie hind limb model./C/in Invest 1994; 93: 662-70.
39. Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM, Symes JF. Intramuscular administration of vascular endothelial growth factor induces dose dependent collateral artery augmenta-tion in a rabbit model of chronic limb ischemia. Circulation 1994; 90: II 228-34.
40. Banters C, Asahara T, Sheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Physiological assessment of augmented vascularity induced by VEGF in ischémie rabbit hindlimb. AmJPh\iioll994.; 267: H1263-71.
41. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Recovery of disturbed endothelium dependent flow in the collateral perfused rabbit ischémie hindlimb after administration of vascular endothelial growth factor. Circulation 1995; 91: 2699-702.
42. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes J, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon injured rat carotid artery. Circulation 1995; 91: 2793-801.
43. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yankopoulos GD. Isolation of angiopoietin-1, a ligand for the Tie2 receptor by secretiontrap expression cloning. Cell 1996; 87: 1161-9.